Back to Results
First PageMeta Content
Acute lymphoblastic leukemia / Leukemia / Asparaginase / Lymphocytic leukemia / Acute leukemia / Oncology


PRESS RELEASE June 17th 2012 ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia
Add to Reading List

Document Date: 2014-07-24 05:45:48

Open Document

File Size: 103,29 KB

Share Result on Facebook

City

Amsterdam / Paris / /

Company

ERYTECH Pharma SA / PRESS RELEASE June 17th 2012 ERYTECH Pharma / GRAALL / ERYTECH Pharma / /

Continent

Europe / /

Country

France / United States / Netherlands / /

Event

FDA Phase / Business Partnership / /

Facility

Hospital Saint Louis / /

IndustryTerm

treatment of Acute Lymphoblastic Leukemia / cooperative / biopharmaceutical company developing medicinal products / /

MedicalCondition

Acute Lymphoblastic leukemia / Adult Acute Lymphoblastic Leukemia / rare diseases / Adult Lymphoblastic Leukemia / /

MedicalTreatment

chemotherapy / /

Organization

European Hematology Association / /

Person

Hervé Dombret / Yann Godfrin / /

Position

Executive Vice President / Vice President Preclinical and Clinical Reseach / /

Product

Acute Lymphoblastic Leukemia The oral / Europe / /

Technology

chemotherapy / /

SocialTag